Intriguingly, METTL17 knockdown exhibited negligible impact on proliferative markers PCNA and Ki-67 in xenograft, prompting speculation that METTL17 influences CRC progression through a proliferative-independent pathway, warranting further investigation. This evidence concerns the gene MKI67 and colorectal carcinoma.